Literature DB >> 28537834

When Respecting Autonomy Is Harmful: A Clinically Useful Approach to the Nocebo Effect.

John T Fortunato1, Jason Adam Wasserman1, Daniel Londyn Menkes1.   

Abstract

Nocebo effects occur when an adverse effect on the patient arises from the patient's own negative expectations. In accordance with informed consent, providers often disclose information that results in unintended adverse outcomes for the patient. While this may adhere to the principle of autonomy, it violates the doctrine of "primum non nocere," given that side-effect disclosure may cause those side effects. In this article we build off previous work, particularly by Wells and Kaptchuk ( 2012 ) and by Cohen ( 2013 ), to suggest ethical guidelines that permit nondisclosure in the case when a nocebo effect is likely to occur on of the basis of nonmaleficence. We accept that that autonomy vis-à-vis informed consent must be forestalled, but salvage much of its role by elaborating a practical clinical approach to postencounter follow-up. In doing so, we reconcile a clinically practicable process of determining conditions of disclosure with long-standing ethical commitments to patients.

Entities:  

Keywords:  disclosure; ethics; informed consent; nocebo effect; placebo effect

Mesh:

Year:  2017        PMID: 28537834     DOI: 10.1080/15265161.2017.1314042

Source DB:  PubMed          Journal:  Am J Bioeth        ISSN: 1526-5161            Impact factor:   11.229


  7 in total

1.  Tell Me the Truth and I Will Not Be Harmed: Informed Consents and Nocebo Effects.

Authors:  Luana Colloca
Journal:  Am J Bioeth       Date:  2017-06       Impact factor: 11.229

2.  One-year results after transitioning from etanercept originator to biosimilar in a setting promoting shared decision-making in rheumatology.

Authors:  Wieland D Müskens; Sanne A A Rongen-van Dartel; Steven Teerenstra; Eddy M M Adang; Piet L C M van Riel
Journal:  Rheumatol Adv Pract       Date:  2020-08-06

3.  Nocebo effects and participant information leaflets: evaluating information provided on adverse effects in UK clinical trials.

Authors:  Nigel Kirby; Victoria Shepherd; Jeremey Howick; Sophie Betteridge; Kerenza Hood
Journal:  Trials       Date:  2020-07-17       Impact factor: 2.279

Review 4.  Placebos as a Source of Agency: Evidence and Implications.

Authors:  Phoebe Friesen
Journal:  Front Psychiatry       Date:  2019-10-25       Impact factor: 4.157

5.  Avoidance of nocebo effects by coincident naming of treatment benefits during the medical interview for informed consent-Evidence from dynamometry.

Authors:  Nina Zech; Matthias Schrödinger; Ernil Hansen
Journal:  Front Psychol       Date:  2022-08-09

6.  Are We Meeting the Current Standards of Consent for Anesthesia? An International Survey of Clinical Practice.

Authors:  Tomas Jovaisa; Ieva Norkiene; Juri Karjagin; Iveta Golubovska; Lukas Gambickas; Migle Kalinauskaite; Evaldas Kauzonas; Dhuleep Wijayatilake
Journal:  Med Sci Monit       Date:  2020-10-05

7.  Nocebo effects by providing informed consent in shared decision making? Not necessarily: a randomized pilot-trial using an open-label placebo approach.

Authors:  Fabian Holzhüter; Johannes Hamann
Journal:  BMC Med Ethics       Date:  2020-10-14       Impact factor: 2.652

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.